Latest News
When it comes to unlocking the secrets of DNA repair, Yale Cancer Center has an armamentarium at work. In the last two years, Yale’s team has made significant advances in targeting the BRCA-dependent DNA repair axis for cancer therapy and determined that both BRCA1 and BRCA2 protein are involved in DNA repair, but they have fundamentally different mechanisms.
- February 25, 2021
Despite poor outcomes nationally and internationally, patients do better when they receive treatment at facilities like Smilow Cancer Hospital. Our unique ability to bring together clinicians and scientists focused on pancreatic cancer is propelling research advances and bringing renewed hope to patients.
- February 17, 2021
Smilow Cancer Hospital, in partnership with the Norma Pfriem Breast Center in Trumbull, Fairfield, and at Bridgeport Hospital, are at the forefront of providing innovative and compassionate multi- disciplinary breast care.
- February 10, 2021
The Head & Neck Cancers Multidisciplinary Clinic at Smilow Cancer Hospital is now available at the Park Avenue Medical Center on Mondays.
- February 01, 2021
Yale Cancer Center held its annual Conclave award ceremony virtually on January 26th to celebrate faculty and provider accomplishments 2020. Faculty and staff were honored with clinical and research prizes including the Ruth McCorkle Oncology Advanced Practice Provider Award, the Class of ‘61 Cancer Research Award, and the Yale Cancer Center Lifetime Achievement Award.
- January 28, 2021
As of January 1, 2021, we are joined by two new Associate Directors to the MD-PhD Program, Drs. Michael Cappello and Silvia Vilarinho.
- January 27, 2021
On January 26, 2021, Smilow Shares in Greenwich presented a talk on Gynecological Cancers and new treatment advances.
- January 11, 2021Source: Damon Runyon News
The Damon Runyon Cancer Research Foundation announced that seven scientists with novel approaches to fighting cancer have been named 2021 recipients of the Damon Runyon-Rachleff Innovation Award. Five initial grants of $400,000 over two years were awarded to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer. Each project will have the opportunity for up to two additional years of funding (four years total for $800,000). This year, “Stage 2” continuation support was granted to two awardees who demonstrated significant progress on their proposed research during the first two years of the award.
- December 14, 2020
Yale Lifesciences Pitchfest 2020, presented by the Blavatnik Fund for Innovation at Yale, took place on Thursday, December 3rd and Friday, December 4th.
- November 18, 2020
On November 17th, Smilow Shares held a virtual series with physicians from our Smilow Cancer Hospital Care Center in Greenwich on Advances in Lung Cancer Screening.
